Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · Real-Time Price · USD
166.87
-5.42 (-3.15%)
At close: Nov 16, 2026, 4:00 PM EST
167.80
+0.93 (0.56%)
After-hours: Nov 16, 2026, 7:57 PM EST

Revolution Medicines Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
36,09315,3988,0834,7202,1151,855
Market Cap Growth
175.57%90.50%71.26%123.15%14.03%-29.43%
Enterprise Value
33,65313,8816,6203,9691,5251,278
Last Close Price
166.8579.6543.7428.6823.8225.17

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
182.67--407.5859.7863.11
PB Ratio
15.029.443.572.583.093.08
P/TBV Ratio
15.489.873.682.693.463.51

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
170.32--342.7843.1143.48

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.500.260.060.050.090.11
Net Debt / Equity Ratio
-1.02-0.98-0.95-0.97-0.85-0.85
Net Debt / EBITDA Ratio
1.461.363.153.752.282.76
Net Debt / FCF Ratio
1.691.753.794.932.473.32
Asset Turnover
0.06--0.010.050.05
Quick Ratio
8.166.9813.9712.8910.489.66
Current Ratio
8.367.1514.2013.0610.659.77
Return on Equity (ROE)
-93.56%-58.07%-29.33%-34.75%-38.63%-34.73%
Return on Assets (ROA)
-32.13%-30.08%-18.66%-20.71%-20.83%-18.00%
Return on Capital Employed (ROCE)
-44.00%-57.30%-28.80%-24.80%-34.40%-27.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-5.48%-7.35%-7.42%-9.25%-11.76%-10.09%
FCF Yield
-3.99%-5.93%-7.02%-7.59%-11.12%-8.29%
Buyback Yield / Dilution
-10.60%-13.35%-48.24%-40.34%-10.74%-32.68%
SEC Filings: 10-K · 10-Q